Zimbabwe has turned down a significant American healthcare agreement valued at $367m (£272m) spanning five years over Washington's demand for sensitive information.
This rejection came to light following a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "skewed".
An official spokesperson has since explained that the US was demanding access to genetic material for scientific study and commercial purposes while was unwilling to share the benefits from future treatments.
"We must now begin the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more negotiations to secure a agreement acceptable to both sides so the country's vital HIV treatment initiative can continue.
Wider Context
This development comes after a comparable case in neighbouring Kenya, where a court blocked a related deal with the US after legal challenges were filed about the safety of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
The agency had managed aid for the US government, but Trump stated its spending was "inefficient" and his government was seeking government-to-government agreements to boost openness and responsibility.
As per reports, Sixteen African countries have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership might have yielded significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded programmes," Tremont said.
However, government spokesperson Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent assurance of access to any medical innovations – such as new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the final treatments would be accessible to our population should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures already set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is designed to ensure that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage continued dialogue with our US partners on how future co-operation could be designed in a manner that respects the sovereignty and interests of each country."
Medical Community Response
Medical experts said it understood the government's concerns, but recommended that negotiations should continue since much of the nation's HIV programmes depended on external financing.
"If technical issues arise, including those involving data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it added.
The situation emphasises the complex tensions between receiving crucial foreign assistance and protecting national sovereignty in an ever more interconnected world.